Metabolic Health Statistics in US 2026 | Rates, Trends & Facts

Metabolic Health in America 2026

The state of metabolic health in the United States has reached a crisis point that demands immediate and sustained national attention. As of 2026, data from the National Health and Nutrition Examination Survey (NHANES), the Centers for Disease Control and Prevention (CDC), and landmark studies published in the Journal of the American Medical Association (JAMA) paint a deeply troubling picture: the overwhelming majority of American adults are not metabolically healthy. Researchers at the University of North Carolina at Chapel Hill’s Gillings School of Global Public Health have described the situation in stark terms — the prevalence of optimal metabolic health in American adults is “alarmingly low.” Only 1 in 8 Americans — just 12.2% of the adult population — meets the criteria for good metabolic health, meaning roughly 87.8% of American adults are living with at least one metabolic risk factor, whether they know it or not. This is not a marginal public health footnote. It is a systemic crisis embedded in everyday American life.

What makes metabolic health statistics in the US in 2026 so significant is the chain reaction they trigger. Poor metabolic health — characterized by impaired blood glucose, elevated triglycerides, low HDL cholesterol, high blood pressure, and excess abdominal fat — does not stay contained. It cascades into type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), and a broad spectrum of chronic conditions that account for the lion’s share of US healthcare spending. The CDC confirms that 90% of the nation’s $4.9 trillion in annual healthcare expenditures go toward people with chronic and mental health conditions, the majority of which are metabolic in origin. Understanding where the US stands on metabolic health in 2026 — across age groups, racial lines, income brackets, and geographic regions — is the foundation for any serious effort to change course.

Interesting Facts: Key Metabolic Health Facts in the US 2026

Source: CDC National Diabetes Statistics Report (January 2026); NHANES 2021–2023; JAMA (January 2026); American Heart Association Heart Disease & Stroke Statistics 2025; UNC Gillings School of Public Health; American Diabetes Association 2026

These numbers deserve to be read slowly, because every percentage point represents millions of real people facing real consequences. The fact that only 12.2% of American adults are metabolically healthy is arguably one of the most important and least discussed statistics in US public health. It means that in a room of 10 Americans, roughly 9 of them carry at least one metabolic abnormality — an elevated waist circumference, a blood sugar creeping toward diabetes, triglycerides too high, HDL cholesterol too low, or blood pressure trending into dangerous territory. These are not distant warning signs. These are the foundational conditions from which heart attacks, strokes, kidney failure, liver disease, and amputations develop. The 115.2 million Americans living with prediabetes — a figure confirmed by the CDC in March 2026 — represent a staggering pool of preventable disease, made more alarming by the fact that 8 in 10 of them have no idea.

The economic dimension of this crisis is equally stunning. Cardiovascular disease alone costs the US healthcare system $233.3 billion per year, and that figure is on course to nearly triple to $1.8 trillion by 2050, driven by the aging of the population, the spread of obesity and hypertension, and the rising cost of cardiovascular medications and procedures. Diabetes accounts for 25% of all US healthcare spending — and medical costs for Americans with diabetes are more than twice those for people without the condition. When you combine metabolic syndrome, obesity, diabetes, hypertension, and NAFLD, you are looking at the dominant drivers of the US healthcare cost crisis. The tragedy is that most of these conditions are, in large part, preventable — which makes the metabolic health statistics for the US in 2026 not just alarming, but deeply urgent.

Metabolic Syndrome Prevalence Rate in the US 2026

METABOLIC SYNDROME PREVALENCE BY AGE GROUP IN THE US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  Ages 60 and above      ████████████████████████████████████████ 56.4%
  Ages 40–59             █████████████████████████████████        ~47%
  All US adults (avg)    ████████████████████████████             39.8%
  Ages 20–39             █████████████████████                    22.2%
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: JAMA, “Trends and Prevalence of the Metabolic Syndrome Among US Adults,” January 20, 2026 (Harvard/MGH study); NHANES 2011–2018; Frontiers in Nutrition, August 2025

A landmark study published in JAMA on January 20, 2026 — conducted by researchers at Harvard Medical School and Massachusetts General Hospital — offered the most up-to-date and sobering look at metabolic syndrome in the United States. Analyzing NHANES data from 2013 to 2023, the researchers found that approximately one-third of US adults met the criteria for metabolic syndrome — defined as having at least three of five risk factors: elevated waist circumference, high triglycerides, low HDL cholesterol, elevated blood pressure, and elevated fasting blood glucose. Critically, the overall prevalence showed no statistically significant improvement across the entire decade from 2013 to 2023, despite enormous investments in healthcare, pharmaceutical development, and public health campaigns. The condition is not retreating. It is entrenched.

The age gradient in metabolic syndrome prevalence is among the most striking features of the data. While 22.2% of adults aged 20–39 are affected — already a troubling figure for a population in its prime — the rate escalates sharply with age, reaching 56.4% among Americans aged 60 and above. This means that the majority of older Americans are living with metabolic syndrome, placing them at dramatically elevated risk for cardiovascular events, kidney disease, and cognitive decline. The 2026 JAMA study specifically flagged climbing rates among older Americans and Black populations, two groups that already face disproportionate healthcare burdens. With the US population aging rapidly and the metabolic risk landscape showing no improvement, the downstream healthcare crisis is not a distant projection — it is already unfolding in clinics and emergency rooms across the country.

Obesity and Metabolic Health Rates in the US 2026

OBESITY PREVALENCE BY AGE GROUP AND SEVERITY IN THE US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  Adults aged 40–59 (obesity)      ████████████████████████████████ 46.4%
  All adults (obesity, overall)    ████████████████████████████     40.3%
  Adults aged 60+ (obesity)        █████████████████████████        38.9%
  Adults aged 20–39 (obesity)      █████████████████████████        35.5%
  Severe obesity (all adults)      ████████                          9.4%
  Women with severe obesity        ████████████                     12.1%
  Men with severe obesity          █████                             6.7%
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: CDC National Center for Health Statistics, Data Brief #508, NHANES August 2021–August 2023; CDC Diabetes Data Brief #516, November 2024

Obesity is the single most powerful driver of metabolic deterioration in the United States, and the latest NHANES data makes this undeniably clear. With 40.3% of US adults living with obesity as of the most recent measurement cycle, the nation is firmly in the grip of what public health researchers have consistently called an epidemic. The 46.4% obesity rate among adults aged 40–59 is particularly alarming because this is the age group with the greatest workforce participation and family caregiving responsibilities — meaning obesity’s economic and social ripple effects extend well beyond individual health. The education gradient is equally revealing: adults with a high school diploma or less face an obesity rate of 44.6%, compared to 31.6% for those with a bachelor’s degree or higher — a 13-percentage-point gap that reflects the deep interplay between socioeconomic status, food environments, and health outcomes.

The metabolic consequences of obesity are severe and well-documented. Adults with obesity face a diabetes prevalence of 24.2%, compared to just 6.8% among adults in the normal weight category — a nearly fourfold difference. For those at the most extreme end of the BMI spectrum, NAFLD prevalence can reach 90%, meaning that nearly every person with a BMI above 40 is carrying some degree of liver fat accumulation. Meanwhile, severe obesity — defined as a BMI of 40 or above — affects 9.4% of all US adults, with women disproportionately affected at 12.1% compared to 6.7% for men. The rise of GLP-1 receptor agonists like semaglutide, which have demonstrated ~15% average weight loss in clinical trials, has introduced a meaningful treatment option, now endorsed in the WHO’s 2025 global guidance for adult obesity care. However, medication access, affordability, and long-term adherence remain significant barriers to translating clinical trial results into population-level improvement.

Diabetes and Prediabetes Rates in the US 2026

DIABETES AND PREDIABETES BURDEN IN THE US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  Prediabetes (adults 18+)    ████████████████████████████████████ 115.2 million
  Diabetes (all ages)         ████████████████                      40.1 million
  Undiagnosed diabetes        █████                                 11.0 million
  Aged 65+ with prediabetes   ████████████████████████████████      52.1% of all 65+
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  1 in 4 adults with diabetes don't know they have it
  8 in 10 adults with prediabetes don't know they have it

Source: CDC National Diabetes Statistics Report, January 21, 2026; CDC Diabetes Report Card, March 16, 2026; American Diabetes Association, 2026

The diabetes and prediabetes data published by the CDC in January 2026 represents one of the clearest signals of metabolic failure at a population scale. 40.1 million Americans — roughly 1 in every 8 people — are living with diabetes, and this figure encompasses a deeply concerning 11 million undiagnosed cases, people who are accumulating metabolic damage without any awareness or treatment. The fact that more than 1 in 4 adults with diabetes doesn’t know they have it is a public health failure that goes beyond individual behavior — it reflects gaps in routine screening, healthcare access, and preventive care infrastructure. The prediabetes figure is even more sobering: 115.2 million American adults — more than 2 in 5 — are in a pre-diabetic state, and a staggering 8 in 10 of them have no idea. Prediabetes is both a warning and an opportunity: with lifestyle intervention, many cases are reversible. Without it, the trajectory toward type 2 diabetes is well-established.

Age amplifies the diabetes risk dramatically. 28.8% of Americans aged 65 and older are living with diabetes, and 52.1% of adults in that same age group have prediabetes — meaning that more than half of older Americans are in a compromised metabolic state. This is not merely a health statistic. It is a forecast for Medicare expenditures, long-term care demand, and quality of life across the aging US population. Diabetes already accounts for 25% of all US healthcare spending, with medical costs for diabetic patients exceeding twice those of their non-diabetic peers. 1.5 million new diagnoses every year mean that without structural intervention — in food policy, urban planning, healthcare access, and preventive medicine — the diabetes burden will continue expanding regardless of advances in pharmaceutical treatment. The CDC’s 2026 diabetes report makes it inescapably clear that America is not managing its way out of this crisis through treatment alone.

Metabolic Health by Race and Ethnicity in the US 2026

METABOLIC SYNDROME PREVALENCE BY RACE/ETHNICITY — KEY TRENDS (US)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  Hispanic Americans          ████████████████████████████████  Highest MetS prevalence
  White Americans             ███████████████████████████       Moderate, rising
  Black Americans             ████████████████████████          Rising, esp. women
  MetS increase (1999–2018)   All racial groups: significant increase (P < 0.001)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: JACC Advances, Yale School of Medicine/Yale-New Haven Hospital, May 2025; JAMA January 20, 2026; CDC Preventing Chronic Disease, 2017

The racial and ethnic disparities in metabolic health in the United States are some of the most persistent and deeply rooted inequities in the entire American healthcare system. A major 2025 study published in JACC Advances by Yale School of Medicine researchers — examining NHANES data from 1999 to 2018 across White, Black, and Hispanic adults — found that metabolic syndrome prevalence increased significantly across all racial and ethnic groups over the two-decade period (P < 0.001). Hispanic Americans carry the highest overall prevalence of metabolic syndrome, with fasting glucose emerging as the most dominant contributing component in that population. Black Americans — particularly women — face sharply elevated risk, with Black women 20% more likely to have metabolic syndrome than their White female counterparts, driven disproportionately by hypertension rather than glucose or lipid abnormalities.

Perhaps most troubling is what the data reveals about treatment gaps. Despite two decades of rising metabolic syndrome rates across all racial groups, the Yale JACC 2025 study found that fewer than 65% of eligible individuals received lipid-lowering therapy, and fewer than 35% received antihyperglycemic therapy — gaps that are most pronounced among Hispanic adults, who are significantly less likely to receive antihypertensive and lipid-lowering medications compared to White adults. NAFLD follows its own racial pattern: Hispanic Americans show the highest prevalence of liver fat accumulation at 45%, compared to 33% for White Americans and 24% for Black Americans — a difference researchers attribute partly to genetic predispositions in lipid metabolism. These disparities are not simply biological. They are the product of differential access to healthcare, food environments, economic stability, and the historical underfunding of community health infrastructure in minority communities across the US.

Cardiovascular Risk and Metabolic Health Costs in the US 2026

CARDIOVASCULAR DISEASE ECONOMIC BURDEN — US 2026 & PROJECTIONS
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  Annual CVD cost (current)       ████████████████████  $233.3 billion/year
  Hypertension healthcare cost    ████████              $160 billion/year → $513B by 2050
  Diabetes healthcare cost        ████████████          $186 billion/year → $765B by 2050
  Projected total CVD cost 2050   ████████████████████████████████████ $1.8 trillion
  Annual productivity loss (CVD)  █████████████         $184.6 billion/year
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: CDC Fast Facts: Health and Economic Costs of Chronic Conditions, August 8, 2025; American Heart Association Presidential Advisory, June 2024; AHA Heart Disease and Stroke Statistics 2025

The financial cost of poor metabolic health in the United States in 2026 is staggering in its current form and catastrophic in its trajectory. Heart disease and stroke — the most deadly downstream consequences of metabolic syndrome, obesity, hypertension, and diabetes — currently cost the US healthcare system $233.3 billion per year, with an additional $184.6 billion lost in worker productivity annually. These are not abstract numbers: they translate to higher insurance premiums, greater national debt, reduced workforce capacity, and enormous personal financial strain for affected families. According to a 2024 American Heart Association Presidential Advisory, annual inflation-adjusted healthcare costs attributable to cardiovascular risk factors are projected to triple between 2020 and 2050, from $400 billion to $1.344 trillion, driven by demographic aging and the inexorable rise of metabolic risk factors that are not being adequately controlled at the population level.

The per-patient cost data is equally striking and policy-relevant. Adults receiving care for hypertension incur an average additional $2,500 per year in healthcare costs; for diabetes, that figure jumps to $7,300 per patient per year. By 2050, healthcare costs attributable to hypertension are projected to surge from $160 billion to $513 billion, while diabetes costs are set to rise from $186 billion to $765 billion — figures that represent a fundamental reshaping of the US healthcare economy. Stroke alone is projected to see a 535% cost increase, reaching $423 billion by 2050, driven by the aging US population and the continuing epidemic of hypertension, a key metabolic risk factor. The AHA’s 2025 report confirms that more than 184 million Americans — exceeding 61% of the US population — are likely to have some type of cardiovascular disease by 2050, making metabolic health not a niche clinical concern but the central challenge of American medicine in the decades ahead.

Physical Activity, Diet, and Metabolic Health in the US 2026

PHYSICAL ACTIVITY COMPLIANCE AMONG US ADULTS 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  Meet BOTH aerobic + muscle-strengthening guidelines:
  Bachelor's degree or higher    ████████████████████████████████ 33.6%
  All adults (overall)           ████████████████████             22.5%
  HS diploma or less             ████████████                     12.2%

  Key Metabolic Health Lifestyle Factors (UNC/NHANES):
  Physically active              = Higher metabolic health
  Normal weight                  = <1/3 are metabolically healthy
  Overweight                     = Only 8.0% metabolically healthy
  Obese                          = Only 0.5% metabolically healthy
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: CDC/MMWR QuickStats, June 2024; UNC Gillings School of Public Health / Metabolic Syndrome and Related Disorders, 2018 (NHANES 2009–2016); PMC Metabolic Syndrome Trends 2022

The lifestyle data surrounding metabolic health in the US tells a story of structural failure more than individual shortcoming. Only 22.5% of American adults meet the federal guidelines for both aerobic physical activity and muscle-strengthening exercise — meaning that more than three-quarters of US adults are not getting the minimum movement their bodies need to sustain metabolic health. The education gradient cuts sharply here: adults with a high school diploma or less meet these guidelines at a rate of just 12.2%, compared to 33.6% for college graduates — a gap that reflects the reality that access to safe outdoor spaces, fitness facilities, time away from work, and knowledge of exercise benefits are all distributed unequally across American society. The UNC Gillings NHANES analysis confirms that physically active individuals have significantly higher rates of metabolic health, and that this association holds even when controlling for weight.

What is perhaps the most counterintuitive — and important — finding in the entire metabolic health data landscape is this: weight alone is not a reliable indicator of metabolic health. Even among normal-weight adults, fewer than one-third are metabolically healthy by comprehensive criteria. Among overweight adults, that figure drops to 8%, and among obese adults, it collapses to just 0.5%. This means that the vast majority of Americans — regardless of the number they see on the scale — are carrying metabolic risk. The 1999–2018 NHANES trend data reveals a particularly troubling pattern: while the prevalence of elevated blood glucose among MetS components rose from 21.18% to 34.68%, and obesity within MetS patients rose from 44.81% to 59.06%, vigorous physical activity actually declined from 23.79% to 16.53% — while antidiabetic drug use surged from 9.87% to 28.63%. Americans are being medicated into partial management of conditions that lifestyle intervention could, in many cases, prevent or reverse. That is the metabolic health challenge of 2026 in its most essential form.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE